Clinical relevance of as-needed treatment with Nalmefene in alcohol-dependent patients

Eitemau Tebyg

• Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers
  gan: Fitzgerald, N.
  Cyhoeddwyd: (2016)
• Risks and benefits of nalmefene in the treatment of adult alcohol dependence: a systematic literature review and meta-analysis of published and unpublished double-blind randomized controlled trials
  gan: Palpacuer, C.
  Cyhoeddwyd: (2015)
• Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta‐analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate
  gan: Palpacuer, C.
  Cyhoeddwyd: (2018)
• MEDICAL MANAGEMENT OF ALCOHOL DEPENDENCE: CLINICAL USE AND LIMITATIONS OF NALTREXONE TREATMENT
  gan: VOLPICELLI, J.R
  Cyhoeddwyd: (1996)
• Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial
  gan: Wayne, S.
  Cyhoeddwyd: (2013)